Anterogen.Co.Ltd (065660) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Anterogen.Co.Ltd (065660) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩281.98 Million ≈ $191.09K USD) by net assets (₩90.04 Billion ≈ $61.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Anterogen.Co.Ltd (065660) market capitalisation for the company's overall valuation and market capitalisation.

Anterogen.Co.Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Anterogen.Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Anterogen.Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anterogen.Co.Ltd ranked by their cash flow conversion efficiency. Explore Anterogen.Co.Ltd (065660) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sao Ta Foods JSC VN:FMC	0.089x
NPC Resources Bhd KLSE:5047	-0.003x
YHN Acquisition I Limited Unit NASDAQ:YHNAU	-0.007x
Scully Royalty Ltd NYSE:SRL	0.012x
BIMobject AB ST:BIM	-0.108x
Kumpulan Kitacon Berhad KLSE:5310	0.092x
Yarrow Bioscience Inc NASDAQ:YARW	-0.166x
NEOOTO Co. Ltd KQ:212560	0.055x

Annual Cash Flow Conversion Efficiency for Anterogen.Co.Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Anterogen.Co.Ltd from 2014 to 2024. View 065660 stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩110.21 Billion ≈ $74.69 Million	₩-860.38 Million ≈ $-583.06K	-0.008x	+49.17%
2023-12-31	₩129.44 Billion ≈ $87.72 Million	₩-1.99 Billion ≈ $-1.35 Million	-0.015x	+16.96%
2022-12-31	₩106.79 Billion ≈ $72.37 Million	₩-1.98 Billion ≈ $-1.34 Million	-0.018x	+29.02%
2021-12-31	₩116.87 Billion ≈ $79.20 Million	₩-3.05 Billion ≈ $-2.06 Million	-0.026x	+52.15%
2020-12-31	₩81.07 Billion ≈ $54.94 Million	₩-4.41 Billion ≈ $-2.99 Million	-0.054x	-125.90%
2019-12-31	₩68.39 Billion ≈ $46.35 Million	₩-1.65 Billion ≈ $-1.12 Million	-0.024x	+10.16%
2018-12-31	₩56.07 Billion ≈ $38.00 Million	₩-1.50 Billion ≈ $-1.02 Million	-0.027x	-429.83%
2017-12-31	₩46.61 Billion ≈ $31.58 Million	₩379.21 Million ≈ $256.98K	0.008x	+311.89%
2016-12-31	₩34.02 Billion ≈ $23.06 Million	₩-130.65 Million ≈ $-88.54K	-0.004x	-107.57%
2015-12-31	₩16.64 Billion ≈ $11.28 Million	₩844.49 Million ≈ $572.30K	0.051x	+165.11%
2014-12-31	₩12.96 Billion ≈ $8.78 Million	₩-1.01 Billion ≈ $-684.63K	-0.078x	--

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$81.71 Million

₩120.58 Billion KRW

Market Cap Rank

#20067 Global

#1062 in Korea

Share Price

₩15160.00

Change (1 day)

-0.39%

52-Week Range

₩14840.00 - ₩58000.00

All Time High

₩197700.00